Worldwide, there is a significant expansion of pharmacists' contribution to vaccination, as more countries are authorising pharmacists to deliver this healthcare and public health service. However, limited and inequitable access to vaccines in some countries, as well as vaccine misinformation and hesitancy, remain significant. This event explores strategies that can be useful in tackling vaccine hesitancy in communities, highlights the economic value of pharmacy-based vaccination to the healthcare system, and further advocates for extended pharmaceutical services in vaccination.

Watch here

HPV (Human Papillomavirus) is the most common sexually transmitted infection, affecting both men and women. It is linked to various cancers, including cervical, anal, oropharyngeal, penile, vaginal, and vulvar cancers. The HPV vaccine is a crucial tool in preventing these cancers and other HPV-related diseases. This digital event highlights the importance of the HPV vaccine, focusing on its safety and efficacy, and strategies to address common misconceptions. It also highlights practical tools that pharmacists can use to enhance patient education and increase vaccine uptake, contributing to increased awareness around HPV and the global effort to reduce HPV-related diseases and cancers.

Watch here

Vaccination is one of the most effective public health interventions to mitigate the burden of disease and saves millions of lives per year. The role of pharmacists as widely documented during the pandemic further reemphasizes the importance of pharmacy-based vaccination in health promotion. The strategic use of vaccination surveillance data can inform and shape public health policies and vaccination approaches. This event will explore the use of surveillance data using international examples of pharmacy-based vaccination services and advocate for extended pharmaceutical services in vaccination. The event will additionally present other global vaccination data-driven projects and their use in policy making. 

Watch video

Tuberculosis (TB) is a preventable and curable disease. However, according to the WHO, in 2022, it affected 10.6 million people worldwide and caused 1.3 million deaths. TB occurs in all countries and in people of all ages. Multi-drug resistant TB (MDR-TB) remains a public health crisis and a threat to health security, with only about two in five people receiving treatment in 2022. In this digital event, experts will explore the role that pharmacists play in the fight against TB, and how this role can be further leveraged. This event marks World TB Day and aims to strengthen pharmacy engagement, foster collaboration and contribute to a TB-free world through collective expertise and commitment.

Watch video

FIP is organizing a series of three webinars centred on critical aspects of vaccination. These webinars aim to provide insights into three key topics to advance pharmacy-based vaccination services:
1. The first event is dedicated to addressing vaccine confidence and aims to explore the factors that influence public trust in vaccines and discuss strategies to bolster vaccine acceptance.
2. The second event focuses on preparing for vaccination campaigns during the winter season. This includes discussions on adapting vaccination strategies for seasonal challenges and ensuring the availability of vaccines during this crucial period.
3. The third event focuses on at-risk or vulnerable groups and examines the importance of reaching and safeguarding these populations and explores ways in which pharmacies can play a crucial role in their vaccination.

Watch video

One of the key objectives of this webinar series is to harness the insights gained from the panel discussions to inform the development of global guidelines for pharmacy practices related to vaccination. These guidelines will serve as a valuable resource for the international pharmacy community, contributing to more effective and inclusive vaccination efforts worldwide.

Watch video

One of the key objectives of this webinar series is to harness the insights gained from the panel discussions to inform the development of global guidelines for pharmacy practices related to vaccination. These guidelines will serve as a valuable resource for the international pharmacy community, contributing to more effective and inclusive vaccination efforts worldwide.

Watch video

This is the 4th and final episode in the FIP series ‘Vaccination: Benefits beyond specific disease prevention’ which aimed to highlight the extensive advantages of vaccination beyond merely guarding against specific pathogens in older adults.

Parts 1 and 2 focused on the evidence base of indirect benefits of vaccination in areas such as cardiovascular health, diabetes and arthritis in older adults and prolonged immune responses that contribute to sustained health. They also underscored the indispensable role of pharmacists in promoting healthy aging through vaccination.

Read more

Building on the Part 2 of the series, Part 3 will focus on the burden of diseases and the risks and costs of not widening access to vaccination. FIP resources will be revisited as well as the process of setting up vaccination at a pharmacy: pre-vaccination, vaccination, post-vaccination and in-depth case studies. The event will take the format of a brief presentations followed by a panel discussion in which experts will join in to share their knowledge and expertise.

Watch video

We all know that the primary goal of vaccination is the prevention of pathogen-specific infection. But what about the indirect benefits of vaccines which drive longer-term immune responses that promote long-term health? This webinar – Part 2 – will share contributions, activities, tools that pharmacists lead and utilise to promote healthy aging in the practice setting. The webinar will highlight the varied but crucial role of pharmacists in vaccination, particularly for older adults, and supporting patients’ quality of life.

Watch video

We all know that the primary goal of vaccination is the prevention of pathogen-specific infection. But what about the indirect benefits of vaccines which drive longer-term immune responses that promote long-term health? This webinar – Part 1 – will delve into technical and evidence-based insights on positive downstream effects of vaccines in older adults including that on cardiovascular events and diseases, diabetes or arthritis

Watch video

Following the pandemic, how to continue to lead the profession globally and support our members during those uncertain times became a core priority for FIP in 2023. As we move on from responding directly to COVID-19 to responding to the aftermath and to readying ourselves for future pandemics and health emergencies, FIP sought to derive key lessons, recommendations and considerations for the future in another report, “Pandemic Preparedness, Response and Recovery: Lessons Learnt for Global Pharmacy”.

Watch video

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Watch video

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, healthcare professionals are in contact with multiple patients daily and are therefore at increased risk of contracting and further spreading vaccine-preventable diseases.

Watch video

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Watch video

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

Watch video

Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.

By the end of the session participants will:
– Understand the specific vaccination needs of several special-risk population groups
– Become familiar with FIP’s resources on vaccination for special-risk groups
– Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups

Watch video

Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.

Watch video

Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.

Watch video

Remuneration of pharmacy vaccinations is one of the key policy enablers of pharmacy-based vaccinations, and thus life-course immunisation. FIP data shows that remuneration models vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies sharing their remuneration models and journeys for the benefit of policy-enablement everywhere.

This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

Watch video

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with diabetes have particular vaccination needs that will be highlighted at this event.

Watch video

Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.

Watch video

Vaccination is one of the most effective measures to prevent disease transmission and help people remain healthy and retain functional ability as they grow older. Adopting a life-course approach to vaccination and providing convenient and accessible vaccination pathways for older adults is essential to achieve high vaccination coverage rates in this particular population group. Pharmacists increasingly offer reliable information and vaccination services around the world. Among the different special-risk population groups, older adults have specific vaccination needs that will be discussed in this event.

Watch video

Influenza and COVID-19 can have an important impact in health, productivity and quality of life, especially for vulnerable populations. Likewise, both diseases have vaccines that are available and support a lower risk of transmission of the disease.

Pharmacists can play a major role in reminding people to get vaccinated, building vaccine confidence and supporting their decision making, dispensing vaccines and, in some countries, administering those vaccines.  The coadministration of these vaccines can lead to an efficient and convenient way of improving vaccine uptake against both diseases. Community pharmacies’s accessibility and credibility put them in an ideal situation to provide this important service, thus making a valuable contribution to disease prevention.

Watch video

This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists’ knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.

Watch video

This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists’ knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.

Watch video

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
– Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
– Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
– Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
– John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Watch video

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
– Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
– Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
– Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
– John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Watch video

La vaccination est l’une des mesures les plus efficaces pour prévenir la transmission des maladies et protéger les populations contre une variété de maladies qui ont un impact important sur les individus et les systèmes de santé. Globalement, en fournissant des services pharmaceutiques centrés sur la personne, les pharmaciens jouent un rôle clé pour garantir une vie saine et promouvoir le bien-être, ainsi que pour favoriser une utilisation plus efficace, rationnelle et généralisée des vaccins. Parmi les différents groupes de population à risque, les personnes vivant avec une affection respiratoire chronique ont des besoins spécifiques en matière de vaccination qui seront discutés lors de cet événement.

À la fin de la session, les participants devraient être en mesure de :

-Comprendre les risques auxquels ce groupe de population particulier est exposé en ce qui concerne les maladies évitables par la vaccination, ainsi que les avantages d’être vacciné.
-Comprendre les principaux vaccins recommandés pour les personnes vivant avec des maladies respiratoires chroniques.
-Discuter du rôle des pharmaciens dans l’éducation à la santé et la vaccination de ce groupe à risque particulier.

Modérateur :
-Peter Guthrey, membre du comité exécutif de la section de la pharmacie sociale et administrative de la FIP ; pharmaciens seniors – politique stratégique The Pharmaceutical Society of Australia – Australie

Panélistes :
-Ema Paulino, Président de l’Association Nationale des Pharmacies, Portugal (ANF), Portugal
Fiona Mosgrove, médecin généraliste NHS Grampian, Royaume-Uni.
-Carmen Baldonedo Mosteiro, pharmacien communautaire. Membre du groupe de travail sur les maladies respiratoires de la Société espagnole de pharmacie communautaire (SEFAC), Société espagnole de pharmacie clinique, familiale et communautaire (SEFAC), Espagne.

Watch video

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:

-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
-Understand the main recommended vaccines for people living with chronic respiratory diseases
-Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
-Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists – strategic policy The Pharmaceutical Society of Australia - Australia

Panelists:
-Ema Paulino,  President  National Association of Pharmacies, Portugal (ANF), Portugal
-Fiona Mosgrove, General Practitioner NHS Grampian, UK
-Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain

Watch video

Around the world, community pharmacies play an increasingly consolidated role in vaccination. During the pandemic, pharmacies’ accessibility made them a convenient place for vaccination against COVID-19 in several countries, increasing vaccination coverage and helping achieve herd immunity. As the world slowly begins to emerge from the pandemic, this event will discuss the role of community pharmacies in COVID-19 booster vaccination, and their challenges in vaccine supply logistics and cold storage solutions, particularly in a post-pandemic scenario. Key interventions by community pharmacists in vaccine supply logistics linked to COVID-19 from different parts of the world will be presented.

Learning objectives:

1. Understand the supply chain and distribution process of COVID-19 vaccines from manufacturer to hospitals, community pharmacies, and the public;

2. Explore the role of community pharmacies in vaccine supply logistics for COVID-19;

3. Discuss the challenges of COVID-19 booster vaccination supply logistics and cold storage solutions in community pharmacies, particularly in a post-pandemic scenario;

4. Explore supply models that involve community pharmacies contributing to population vaccination coverage in a post-pandemic scenario.

Moderator:
– Catherine Duggan, Chief Executive Officer FIP, the Netherlands

Panellists:
– Vibhu Paudyal, Associate Professor in Clinical Pharmacy University of Birmingham, UK
– Ronald T. Piervincenzi, Ph.D., Chief Executive Officer USP, USA
– Loganathan Fahrni, Senior lecturer and pharmacist Universiti Teknologi MARA, Malaysia

Watch video

The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.

Watch video

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

Dans de nombreux pays, les taux de couverture vaccinale sont sous-optimaux et les services de vaccination sont essentiellement axés sur l’enfance.

Les objectifs visant à développer les parcours de vaccination consistent notamment à disposer de points de vaccination plus nombreux et facilement accessibles, d’un plus grand nombre de professionnels capables de fournir le service à un plus grand nombre de personnes et d’offrir des conseils sur les vaccins fondés sur des données probantes.

Watch video

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

En muchos países, las tasas de cobertura de vacunación no son óptimas, y los servicios de vacunación se centran principalmente en la infancia. Los objetivos para ampliar las vías de acceso a la vacunación incluyen disponer de más puntos de vacunación de fácil acceso, más profesionales que puedan prestar el servicio a un mayor número de personas y ofrecer asesoramiento basado en la evidencia sobre las vacunas. En este evento se debatirán los factores que impulsan y obstaculizan el entendimiento interprofesional, la cooperación y el reparto de tareas en el ámbito de la vacunación en la región, así como la autoridad normativa concedida a los distintos profesionales sanitarios para prescribir y/o administrar vacunas.

Watch video

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Watch video

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

Watch video

El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP.

Watch video

In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.

Watch video

In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.

Watch video

In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.

Watch video

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event gathered different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.

Watch video

In the third of six regions we focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Watch video

This digital event discussed how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.

Watch video

In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.

Watch video

En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.

Watch video

In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region, join us for a true regional perspective.

Watch video

Watch Video

This event focused on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists discussed working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

Watch video

The World Health Organization has listed vaccine hesitancy — concerns related to vaccination or outright refusal to receive vaccines despite availability — as one of the top 10 threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine-preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against COVID-19.

Watch video

This event focused on the issues around health literacy and access to information. The societal influences on the ‘’infodemic’’ will be laid out, also the role of health care professionals, health workers and be vaccine hesitant people. We considered all the policy elements that need to be addressed to overcome this, identifying tools to overcome these issues from a range of angles and the role pharmacy can play.

Watch video

Episode 3 examines inequities in gender access to vaccines to inform pharmacy policy. Various angles to vaccinations and the gender will be discussed including general gender access, terms of empowering women as caregivers to support vaccinations, the impact of COVID-19 on gender inequity, and the issues around gender inequity in the workforce (which is especially important to discuss in 2020 Year of the Health Worker).

Watch Video

The World Health Organization lists vaccine hesitancy—concerns related to vaccination or outright refusal to receive vaccines despite availability—as one of the top ten threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against novel Sars-Cov-2 virus.

Often times, “one-size-fits-all” vaccine promotion efforts can backfire when presented to individuals who are already sceptical of vaccines. This event will outline evidenced-based strategies for developing pharmacy-led immunization campaigns which communicate the value of vaccines to specific patient groups in order to build vaccine confidence and improve uptake.

Watch Video

Episode 2 takes a life-course approach to discussing vaccination. The panelists will focus on age and explore vaccines equity and access through life’s ages and stages – from childhood (including pregnancy) to later adulthood – from a pharmacy perspective. They will focus on setting out the policy issues and immediate next steps, determining what pharmacy needs to do to singularly affect the most change in this area.

Watch Video

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. As such, FIP considers that it is essential to promote dialogue and understanding around these perceptions among healthcare professionals’ organisations at the international level, so that these can be cascaded to the regional, country and local levels.

Watch Video

Episode 1, the digital programme’s Opening Event, will set the stage for the entire programme. Together we will revisit the key outcomes of the Transforming Vaccination 2020 programme, specifically focusing on the outcomes relating to shaping policy around equity, access and sustainability and how they are shaping the FIP vaccination agenda for 2021. We will also describe this year’s programme, outline its key aims and objectives as well as outcomes. This special programme opener is for anyone invested in transforming and shaping vaccination in pharmacy!

Watch Video

FIP’s Regulators’ Forum presented a new regulatory vaccination preparedness self-assessment tool and risk assessment. Foundational regulatory needs were presenteded to ensure oversight, quality assurance and public protection as the scope of pharmacist’s patient care is expanded to include prescribing, vaccination and testing in order to address population health needs during a pandemic. A brief overview of the data collected by FIP on the role of pharmacists in vaccinations and other FIP documents was also presented.

Watch Video

This session will examine the application of the concepts of the Health Belief Model (HBM) which is one of the first and still most commonly used frameworks or theories of health behavior. There has been successful application of the HBM in health and wellness programs, including immunization and chronic diseases management. As such, the application of HBM will be illustrated in a flu awareness campaign that targeted Lebanese University students. Examples of improving immunization rates and addressing patient perceptions in an ambulatory care setting in the U.S. will also be discussed.

Watch Video

Although pharmacists have administered vaccines in several countries for years, this role is still new or even unknown to the profession in many parts of the world. As a role that involves direct contact with the patient and the administration of a product by injection, it may still generate some concerns among pharmacists with regards to the administration procedure, common errors and the management of anaphylactic reactions. This webinar will describe such procedures and address common questions and concerns.

Watch Video

This global virtual Summit – the programme finale – is a high-level event in which we will recap the primary outcomes of the 24-event digital series. Together, we will adopt the FIP Commitment to Action on Vaccination in Pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

Watch Video

This roundtable event follows 6 regional events – episodes 3.1 to 3.6 of the programme – which dissected priorties, needs and barriers across the world’s six regions. We now bring back the key outcomes from the six regional discussions int one roundtable to identify common priorities for action to transform vaccination. Each regional perspective will be represented by the panelists, alongside other leaders and stakeholders.

Watch Video

Event 3.6 focuses on the regional needs and drivers for transforming vaccination in the Americas region. This involves discussing the progress made in countries in the Americas with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation.

Watch Video

In the fifth of six regions we dissect, event 3.5 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves discussing the progress made in Africa with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from Africa join us for a true regional perspective.

Watch Video

In the fourth of six regions we dissect, event 3.4 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific. This involves discussing the progress made in Western Pacific countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the Western Pacific join us for a true regional perspective.

Watch Video

In the third of six regions we dissect, event 3.3 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region (EMR). This involves discussing the progress made in EMR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the EMR join us for a true regional perspective.

Watch Video

In the second of six regions we dissect, event 3.2 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region (SEAR). This involves discussing the progress made in SEAR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the SEAR join us for a true regional perspective.

Watch Video

In the first of six regions we dissect, event 3.1 focuses on the regional needs and drivers for transforming vaccination in Europe. This involves discussing the progress made in European countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Watch Video

This event will discuss how the quality, efficacy and safety of vaccines are built into their development and manufacturing processes, including the clinical research they undergo and the strict regulatory assessment that precedes their marketing authorization. In addition, speakers will discuss how to make such processes understood and well-known by the public in a transparent and clear manner, in order to build confidence in vaccines and address the grave problem of vaccine hesitancy and anti-vaccines movements, i.e., the refusal to get vaccinated despite the availability of vaccines.

Watch Video

In this episode – “Setting Transformation Goals for Vaccination Globally” – is a roundtable discussion that focuses on the role of the FIP Development Goals in the transformation of pharmacist vaccination globally and regionally. The discussion will focus on the development of transformative goals and how these goals will be used to deliver pharmacist vaccinators in all jurisdictions, resulting in increased vaccination rates worldwide

Watch Video

In this episode – “Pharmacist Vaccinators and Antimicrobial Stewardship” – is an interview format that focuses on the FIP Development Goal 17: Antimicrobial Stewardship from the perspective of vaccination by a pharmacist. The role of vaccination in antimicrobial stewardship, preserving antimicrobial effectiveness, preventing antimicrobial resistance, and the promise of addressing these issues that pharmacists vaccinators will deliver.

Watch Video

In this episode – “Pharmacist Vaccinators as a way to improve access to medicines” – is an interview format that focuses on the FIP Development Goal 18: Access to Medicines and Services from the perspective of vaccination by a pharmacist. The role of pharmacists in ensuring that vaccinations are widely and easily accessible by all people in all areas of the world, and the expertise of pharmacists in delivering the logistics and services needed to increase vaccination rates.

Watch Video

In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

Watch Video

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

Watch Video

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

Watch Video

In this episode – “Vaccination: From Specialist Practice to Everyday Practice” – is an interview format that focuses on the FIP Development Goal 4: Advanced & Specialist Development from the perspective of vaccination by a pharmacist. We discuss the process required to take vaccination by pharmacists from a specialized field that few pharmacists deliver in some jurisdictions, to a standard part of pharmacists’ care in all settings and locations.

Watch Video

La grippe saisonnière représente une charge de morbidité importante pour le système de santé et un risque pour plusieurs groupes de population, notamment les personnes âgées, les personnes souffrant d’affections sous-jacentes, les femmes enceintes et d’autres.
La menace d’une deuxième épidémie de COVID-19 est très réelle, et le risque que les deux virus entraînent une morbidité et une mortalité combinées ne peut être négligé.

Watch Video

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Watch Video

Watch Video

Tras la irrupción de la infección respiratoria por el nuevo coronavirus SARS-CoV-2, el desarrollo de vacunas capaces de proporcionar protección individual y poblacional frente a este virus se presenta como uno de los pilares fundamentales para controlar su expansión. Por otro lado, entre los numerosos efectos de la pandemia actual, conviene destacar los relacionados con la interrupción de los servicios básicos de salud, entre ellos, los programas de vacunación que están sufriendo importantes caídas y demoras en la mayoría de los países. En esta conferencia se abordarán las diferentes vacunas que se están en progreso para COVID-19, las tecnologías utilizadas y los adelantos en su desarrollo, así como la importancia de reestablecer y mantener los sistemas de inmunización.

Watch Video

Watch Video

Watch Video

Watch Video

Watch video

Watch Video

Watch Video

Watch Video

Watch Video

Watch Video

Watch Video

Watch Video

Watch Video

Watch Video